Treprostinil

Back to search

Molecule Structure

Scientific Name

Treprostinil

Description of the Drug

Treprostinil is a prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00374

Brand Name(s)

Remodulin, Tyvaso

Company Owner(s)

Sandoz Inc, Teva Pharmaceuticals Usa, Alembic Global Holding Sa, Par Sterile Products Llc, Dr Reddys Laboratories Ltd, United Therapeutics Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Prostanoid IP receptor SINGLE PROTEIN AGONIST CHEMBL1995

Unichem Links

SureChEMBL SCHEMBL4349618
Human Metabolome Database HMDB0014518
WDI U-62840
DrugBank DB00374
PubChem: Thomson Pharma 14854155 14878554
PubChem 6918140
LINCS LSM-45331
Nikkaji J430.982K
DrugCentral 2720
Metabolights MTBLC50861
ChemicalBook CB32460050
Guide to Pharmacology 5820
GSRS 87c7535e-4133-46ec-9879-bc4c9fee2f82
rxnorm TREPROSTINIL ORENITRAM TYVASO REMODULIN TREPROSTINIL DIOLAMINE
ChEBI 50861
ZINC ZINC000003800475